I Visit insilico.com →
Founded2014
HQBoston, Massachusetts
MakerAlex Zhavoronkov (founder, CEO)
CategoryAI drug discovery
The lenses
Scored on its own merits — not rolled up from the finds we publish.
Novelty 4
Impact · breadth 3
Impact · depth 4
Actionable 3
Substance 5
Hype 4
Related concepts
Appears in finds
Top 5 · Insilico Medicine
Lens
Window
Theme
Overall = breadth + depth + substance + ½·novelty + freshness (a small boost that halves each week)
01 
See the full feed → demoBiotech & Synthetic Biology
$115 million in hand
Eli Lilly licensed a batch of Insilico's AI-designed drug candidates in a deal headlined at $2.75 billion — but only $115 million of that is money Insilico actually has.
Overall▄▃▃▂▅▄high · independentInsilico Medicine / Eli Lilly
No finds in this window — widen it to see more.
How this connects
Tap a node to open it
Insilico MedicineLongevity & HealthBiotech & Synthetic Biology$115 million in handAI drug discoveryProtein language modelArtificial IntelligenceDemis HassabisJennifer DoudnaEli LillyAlphabetJ. Craig Venter InstituteThe edit that lowers cholesterolVERVE-102Verve TherapeuticsCRISPR that makes its own couriersUnited TherapeuticsColossal BioscienceseGenesisVITARIEvery CurePig kidneys enter trials